Catalent, Inc. – NYSE:CTLT

Financial Health
0
1
2
3
4
5
6
7
8
9

Catalent stock price monthly change

+10.25%
month

Catalent stock price quarterly change

+10.25%
quarter

Catalent stock price yearly change

+53.04%
year

Catalent key metrics

Market Cap
11.52B
Enterprise value
16.25B
P/E
27.85
EV/Sales
3.41
EV/EBITDA
15.14
Price/Sales
2.48
Price/Book
2.41
PEG ratio
-3.02
EPS
-1.24
Revenue
4.49B
EBITDA
338M
Income
-227M
Revenue Q/Q
N/A
Revenue Y/Y
N/A
Profit margin
8.62%
Oper. margin
13.77%
Gross margin
32.71%
EBIT margin
13.77%
EBITDA margin
7.52%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Catalent stock price history

Catalent stock forecast

Catalent financial statements

Average Price Target
Last Year

$63.5

Based on estimate of 2 analysts
  • Analysts Price target

  • Financials & Ratios estimates

Catalent, Inc. (NYSE:CTLT): Profit margin
Jun 2022 1.31B 187M 14.24%
Mar 2023 1.03B -227M -21.89%
Jun 2023 1.06B -86M -8.05%
Mar 2024 1.07B -101M -9.4%
0%
Yield TTM
Catalent, Inc. (NYSE:CTLT): Payout ratio
Payout ratio 0%
Catalent, Inc. (NYSE:CTLT): Dividend Yield
2020 0.33%
2021 0.12%
2022 0.02%
2023
2024
Catalent, Inc. (NYSE:CTLT): Debt to assets
Dec 2022 11147000000 6.23B 55.93%
Mar 2023 10830000000 6.12B 56.57%
Jun 2023 10782000000 6.14B 57.01%
Mar 2024 9879000000 6.26B 63.45%
Catalent, Inc. (NYSE:CTLT): Cash Flow
Jun 2022 69M -394M 1M
Mar 2023 -64M -110M -25M
Jun 2023 203M -128M -51M
Mar 2024 12M -74M 0

Catalent alternative data

Catalent, Inc. (NYSE:CTLT): Job openings
Aug 2023 387
Sep 2023 457
Oct 2023 499
Nov 2023 503
Dec 2023 511
Jan 2024 426
Feb 2024 363
Apr 2024 201
May 2024 213
Jun 2024 221
Jul 2024 219
Catalent, Inc. (NYSE:CTLT): Employee count
Aug 2023 19,000
Sep 2023 17,800
Oct 2023 17,800
Nov 2023 17,800
Dec 2023 18,000
Jan 2024 18,000
Feb 2024 18,000
Mar 2024 18,000
Apr 2024 18,000
May 2024 18,000
Jun 2024 18,000
Jul 2024 18,000

Catalent other data

100.00% 0.00%
of CTLT is owned by hedge funds
177.94M +2.38M
shares is hold by hedge funds

Catalent, Inc. (NYSE:CTLT): Insider trades (number of shares)
Period Buy Sel
Mar 2024 0 387
Jun 2024 0 1401
Jul 2024 0 12919
Aug 2024 0 6964
Sep 2024 0 1994
Oct 2024 0 320
Nov 2024 0 2800
Transaction Date Insider Security Shares Price per share Total value Source
Sale
RYAN MICHELLE R director
Common Stock 2,800 $59.7 $167,160
Sale
FERRARO JOSEPH ANTHONY officer: SVP, General Counsel, ..
Common Stock 320 $59.97 $19,190
Sale
MCERLANE DAVID officer: Group President, Biolo..
Common Stock 1,994 $59.97 $119,580
Sale
HOPSON RICKY officer: Pres. BioProduct Deliv..
Common Stock 662 $59.56 $39,429
Sale
GUNTHER SCOTT officer: SVP, Quality & Reg. Af..
Common Stock 666 $59.55 $39,660
Sale
FERRARO JOSEPH ANTHONY officer: SVP, General Counsel, ..
Common Stock 608 $59.58 $36,225
Sale
EVOLI LISA officer: SVP, Chief HR Officer
Common Stock 3,859 $59.67 $230,267
Sale
GENNADIOS ARISTIPPOS officer: Group Pres. Pharma & C..
Common Stock 1,169 $59.55 $69,614
Sale
MASELLI ALESSANDRO director, officer.. Common Stock 9,088 $58.76 $534,011
Sale
HOPSON RICKY officer: Pres. BioProduct Deliv..
Common Stock 206 $58.67 $12,086
Wednesday, 18 December 2024
prnewswire.com
reuters.com
Saturday, 14 December 2024
reuters.com
globenewswire.com
businesswire.com
Friday, 6 December 2024
globenewswire.com
businesswire.com
reuters.com
Thursday, 5 December 2024
zacks.com
Friday, 22 November 2024
reuters.com
Wednesday, 13 November 2024
reuters.com
zacks.com
Wednesday, 6 November 2024
zacks.com
Tuesday, 5 November 2024
zacks.com
reuters.com
Monday, 4 November 2024
reuters.com
Thursday, 24 October 2024
zacks.com
Wednesday, 23 October 2024
reuters.com
Monday, 21 October 2024
reuters.com
Thursday, 17 October 2024
reuters.com
Wednesday, 16 October 2024
zacks.com
Monday, 14 October 2024
reuters.com
globenewswire.com
businesswire.com
Thursday, 10 October 2024
reuters.com
Thursday, 3 October 2024
zacks.com
zacks.com
Thursday, 12 September 2024
zacks.com
Friday, 30 August 2024
reuters.com
zacks.com
  • When is Catalent's next earnings date?

    Unfortunately, Catalent's (CTLT) next earnings date is currently unknown.

  • Does Catalent pay dividends?

    No, Catalent does not pay dividends.

  • How much money does Catalent make?

    Catalent has a market capitalization of 11.52B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 2.46% to 4.38B US dollars.

  • What is Catalent's stock symbol?

    Catalent, Inc. is traded on the NYSE under the ticker symbol "CTLT".

  • What is Catalent's primary industry?

    Company operates in the Healthcare sector and Drug Manufacturers - Specialty & Generic industry.

  • How do i buy shares of Catalent?

    Shares of Catalent can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are Catalent's key executives?

    Catalent's management team includes the following people:

    • Mr. Alessandro Maselli Pres & Chief Operating Officer(age: 53, pay: $3,780,000)
    • Mr. John R. Chiminski Chairman & Chief Executive Officer(age: 61, pay: $3,170,000)
    • Mr. Steven L. Fasman Senior Vice President, Gen. Counsel & Corporation Sec.(age: 62, pay: $1,320,000)
    • Ms. Karen A. Flynn Chief Commercial Officer(age: 62, pay: $1,150,000)
    • Mr. Thomas P. Castellano Senior Vice President & Chief Financial Officer(age: 45, pay: $731,920)
  • How many employees does Catalent have?

    As Jul 2024, Catalent employs 18,000 workers.

  • When Catalent went public?

    Catalent, Inc. is publicly traded company for more then 11 years since IPO on 31 Jul 2014.

  • What is Catalent's official website?

    The official website for Catalent is catalent.com.

  • Where are Catalent's headquarters?

    Catalent is headquartered at 14 Schoolhouse Road, Somerset, NJ.

  • How can i contact Catalent?

    Catalent's mailing address is 14 Schoolhouse Road, Somerset, NJ and company can be reached via phone at +7 325376200.

  • What is Catalent stock forecast & price target?

    Based on 2 Wall Street analysts` predicted price targets for Catalent in the last 12 months, the avarage price target is $63.5. The average price target represents a null change from the last price of $0.

Catalent company profile:

Catalent, Inc.

catalent.com
Exchange:

NYSE

Full time employees:

17,000

Industry:

Drug Manufacturers - Specialty & Generic

Sector:

Healthcare

Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. It operates through four segments: Biologics, Softgel and Oral Technologies, Oral and Specialty Delivery, and Clinical Supply Services. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products, such as prescription drugs, over-the-counter medications, dietary supplements, unit-dose cosmetics, and animal health medicinal preparations. The Biologics segment provides biologic cell-line; develops and manufactures cell therapy and viral based gene therapy; formulation, development, and manufacturing for parenteral dose forms, including vials, prefilled syringes, vials, and cartridges; and analytical development and testing services. The Oral and Specialty Delivery segment offers formulation, development, and manufacturing across a range of technologies along with integrated downstream clinical development and commercial supply solutions. This segment also offers oral delivery solutions platform comprising pre-clinical screening, formulation, analytical development, and current good manufacturing practices services. The Clinical Supply Services segment offers manufacturing, packaging, storage, distribution, and inventory management for drugs and biologics clinical trials. It also offers FastChain demand-led clinical supply services. The company serves pharmaceutical, biotechnology, and consumer health companies; and companies in other healthcare market segments, such as animal health and medical devices, as well as in cosmetics industries. Catalent, Inc. was incorporated in 2007 and is headquartered in Somerset, New Jersey.

14 Schoolhouse Road
Somerset, NJ 08873

CIK: 0001596783
ISIN: US1488061029
CUSIP: 148806102